Screening for adverse events

Journal of Evaluation in Clinical Practice

Volumn 5, Issue 1, 1999, Pages 23-32

  Karson, Andrew S ^a   Bates, David W ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Adverse events; Algorithms; Chart review; Criteria; Risk management; Screening; Technology

Indexed keywords

ADVERSE DRUG REACTION; ALGORITHM; ARTICLE; COMPUTER SYSTEM; HEALTH CARE QUALITY; PRIORITY JOURNAL; RISK MANAGEMENT; TREATMENT OUTCOME;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ALGORITHMS; HOSPITAL RECORDS; HUMANS; IATROGENIC DISEASE; MEDICATION ERRORS; QUALITY ASSURANCE, HEALTH CARE; RISK MANAGEMENT; SENTINEL SURVEILLANCE; UNITED STATES;

EID: 0032909789     PISSN: 13561294     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2753.1999.00158.x     Document Type: Article

References (49)

1. Andrews L.B., Stocking C., Krizek T., et al. (1997) An alternative strategy for studying adverse events in medical care. Lancet 349, 309-313.
2. Bates D.W., Boyle D.L., Vander Vliet M.B., Schneider J. & Leape L.L. (1995a) Relationship between medication errors and adverse drug events. Journal of General Internal Medicine 10, 199-205.
3. Bates D.W., Leape L.L. & Petrycki S. (1993) Incidence and preventability of adverse drug events in hospitalized adults. Journal of General Internal Medicine 8, 289-294.
4. Bates D.W., O'Neil A.C., Boyle D. et al. (1994) Potential identifiability and preventability of adverse events using information systems. Journal of the American Medical Informatics Association 1, 404-411.
5. Bates D.W., O'Neil A.C., Petersen L.A., Lee T.H. & Brennan T.A. (1995b) Evaluation of screening criteria for adverse events in medical patients. Medical Care 33, 452-462.
6. Bates D.W., Spell N., Cullen D.J. et al. (1997) The costs of adverse drug events in hospitalized patients. Journal of the American Medical Association 227, 307-311.
7. Bates D.W., Cullen D., Laird N., et al. Quality Review Bulletin (1995c) Incidence of adverse drug events and potential adverse drug events: implications for prevention. Journal of the American Medical Association 274, 29-34.
8. Berry L.L., Segal R., Sherrin T.P. & Fudge K.A. (1988) Sensitivity and specificity of three methods of detecting adverse drug reactions. American Journal of Hospital Pharmacy 45, 1534-1539.
9. Brennan T.A., Leape L.L., Laird N., et al. (1991a) Incidence of adverse events and negligence in hospitalized patients: Results from the Harvard Medical Practice Study I. New England Journal of Medicine 324, 370-376.
10. Brennan T.A., Hebert L.E., Laird N.M. et al. (1991b) Hospital characteristics associated with adverse events and substandard care. Journal of the American Medical Association 265, 3265-3269.
11. Brennan T.A., Localio R.J. & Laird N.L. (1989) Reliability and validity of judgments concerning adverse events suffered by hospitalized patients. Medical Care 27, 1148-1157.
12. California Medical Association (1977) Report of the Medical Insurance Feasibility Study. California Medical Association, Sacramento, CA.
13. Chester M., Chen L. & Kaski J.C. (1995) Identification of patients at high risk for adverse coronary events while awaiting routine coronary angioplasty. British Heart Journal 73, 216-222.
14. Classen D.C., Pestotnik S.L., Evans R.S. & Burke J.P. (1991) Computerized surveillance of adverse drug events in hospital patients. Journal of the American Medical Association 266, 2847-2851.
15. Classen D.C., Pestotnik S.L., Evans R.S., Lloyd J.F. & Burke J.P. (1997) Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. Journal of the American Medical Association 277, 301-306.
16. Cullen D.J., Bates D.W., Small S.D., Cooper J.B., Nemeskal A.R. & Leape L.L. (1995) The incident reporting system does not detect adverse drug events: a problem for quality improvement. Joint Commission Journal on Quality Improvement 21, 541-548.
17. DesHarnais S.I., McMahon Jr, L.F., Wroblewski R.T. & Hogan A.J. (1990) Measuring hospital performance. The development and validation of risk-adjusted indexes of mortality, readmissions, and complications. Medical Care 28, 1127-1141.
18. Dubois R.W., Brook R.H. & Rogers W.H. (1987b) Adjusted hospital death rates: a potential screen for quality of medical care. American Journal of Public Health 77, 1162-1166.
19. Dubois R.W., Rogers W.H., Moxley J.H., Draper D. & Brook R.H. (1987) Hospital inpatient mortality: is it a predictor of quality? New England Journal of Medicine 317, 1674-1680.
20. Evans R.S., Pestotnik S.L., Classen D.C., Horn S.D., Bass S.B. & Burke J.P. (1994) Preventing adverse drug events in hospitalized patients. Annals of Pharmacotherapy 28, 523-527.
21. Faich G.A. (1991) National adverse drug reaction reporting. 1984-1989. Archives of Internal Medicine 151, 1645-1647.
22. Fischer G., Fetters M.D., Munroe A.P., et al. (1997) Adverse events in primary care identified from a risk-management database. Journal of Family Practice 45, 40-46.
23. Frankl S.E., Breeling J.L. & Goldman L. (1991) Preventability of emergent hospital readmission. American Journal of Medicine 90, 667-674.
24. Goldman R. (1989) Development of a Veterans Administration occurrence screening program. Quality Review Bulletin 15(10), 315-319.
25. Goldman R.L. (1992) The reliability of peer assessments of quality of care. Journal of the American Medical Association 267, 958-960.
26. Institute of Medicine (1985) Injury in America. National Academy Press, Washington, DC.
27. Jha A.K., Kuperman G.J., Teich J.M. et al. (1998) Identifying adverse drug events: development of a computer-based monitor and comparison to chart review and stimulated voluntary report. Journal of the American Medical Informatics Association 5(3), 305-314.
28. Johnson W.G., Brennan T.A., Newhouse J.P. (1992) et al. The economic consequences of medical injuries. Implications for a no-fault insurance plan. Journal of the American Medical Association 267, 2487-2492.
29. Kazandjian V.A., Lawthers J., Cernak C.M. et al. (1993) Relating outcomes to processes of care: the Maryland Hospital Association's quality indicator project (QI Project). Joint Commission Journal on Quality Improvement 19, 530-538.
30. Keith M.R., Bellanger-McCleery R.A. & Fuchs J.E., Jr. (1989) Multidisciplinary program for detecting and evaluating adverse drug reactions. American Journal of Hospital Pharmacy 46, 1809-1812.
31. Kessler D.A. (1993) Introducing MEDWatch. A new approach to reporting medication and device adverse effects and product problems. Journal of the American Medical Association 269, 2765-2768.
32. Leape L.L., Brennan T.A., Laird N.M., et al. (1991) The nature of adverse events in hospitalized patients: Results from the Harvard Medical Practice Study II. New England Journal of Medicine 324, 377-384.
33. Leape L.L., Bates D.W., Cullen D.J. et al. (1995) Systems analysis of adverse drug events. Journal of the American Medical Association 274, 35-43.
34. Lesar T.S., Briceland L.L. & Stein D.S. (1997) Factors related to errors in medication prescribing. Journal of the American Medical Association 277, 312-317.
35. Medical Practice Study (1990) Patients, doctors and lawyers: Studies of medical injury in New York, Harvard University, Boston, MA.
36. Milne R. & Clarke A. (1990) Can readmission rates be used as an outcome indicator? British Medical Journal 301, 1139-1140.
37. O'Hara D.S. & Carson N.J. (1997) Reporting of adverse events in Victoria, 1994-1995. Medical Journal of Australia 166, 460-463.
38. O'Neil A.C., Petersen L.A., Cook E.F., Bates D.W., Lee T.H. & Brennan T.A. (1993) Physician reporting compared with medical-record review to identify adverse medical events. Annals of Internal Medicine 119, 370-376.
39. Park R.E., Brook R.H., Kosecoff J. et al. (1990) Explaining variations in hospital death rates: randomness, severity of illness, quality of care. Journal of the American Medical Association 264, 484-490.
40. Petersen L.A., Brennan T.A., O'Neil A.C. et al. (1994) Does housestaff discontinuity of care increase the risk for preventable adverse events? Annals of Internal Medicine 121, 866-872.
41. Petersen L.A., Orav E.J., Teich J.M., O'Neil A.C. & Brennan T.A. (1998) Does housestaff discontinuity of care increase the risk for preventable adverse events? Joint Commission Journal on Quality Improvement 24, 77-87.
42. Rogers A.S., Israel E., Smith C.R., et al. (1988) Physician knowledge, attitudes, and behavior related to reporting adverse drug events. Archives of Internal Medicine 148, 1596-1600.
43. Rubin H.R., Rogers W.H., Kahn K.L., Rubenstein L.V. & Brook R.H. (1992) Watching the doctor-watchers: how well do peer review organization methods detect hospital care quality problems? Journal of the American Medical Association 267, 2349-2354.
44. Sanazaro P.J. & Mills D.H. (1991) A critique of the use of generic screening in quality assessment. Journal of the American Medical Association 265, 1977-1981.
45. Schiff G.D. (1990) Using a computerized discharge summary data base check for adverse drug reaction monitoring. Quarterly Review Bulletin 15(4), 149-155.
46. Scott H.D., Thacher-Renshaw A., Rosenbaum S.E. et al. (1990) Physician reporting of adverse drug reactions. Results of the Rhode Island Adverse Drug Reaction Reporting Project. Journal of the American Medical Association 263, 1785-1788.
47. Thomas E.J., Burstin H., Orav E.J., et al. (1997) Incidence of, and risk factors for, adverse events and negligent care in Utah and Colorado in 1992. Journal of General Internal Medicine 12(suppl.), 81.
48. Wilson R.M., Runciman W.B., Gibberd R.W. et al. (1995) The Quality of Australian Health Care Study. Medical Journal of Australia 163, 458-471.
49. Wolff A.M. (1996) Limited adverse occurrence screening: using medical record review to reduce hospital adverse patient events. Medical Journal of Australia 164, 458-461.